GB201617206D0 - Method - Google Patents

Method

Info

Publication number
GB201617206D0
GB201617206D0 GBGB1617206.6A GB201617206A GB201617206D0 GB 201617206 D0 GB201617206 D0 GB 201617206D0 GB 201617206 A GB201617206 A GB 201617206A GB 201617206 D0 GB201617206 D0 GB 201617206D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1617206.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psioxus Therapeutics Ltd
Original Assignee
Psioxus Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psioxus Therapeutics Ltd filed Critical Psioxus Therapeutics Ltd
Priority to GBGB1617206.6A priority Critical patent/GB201617206D0/en
Publication of GB201617206D0 publication Critical patent/GB201617206D0/en
Priority to JP2018531337A priority patent/JP2019508017A/en
Priority to IL260027A priority patent/IL260027B/en
Priority to PCT/EP2016/081817 priority patent/WO2017103290A1/en
Priority to SG11201805137XA priority patent/SG11201805137XA/en
Priority to SG11201805136TA priority patent/SG11201805136TA/en
Priority to CN201680076032.7A priority patent/CN108697746A/en
Priority to MX2018007249A priority patent/MX2018007249A/en
Priority to KR1020187020443A priority patent/KR20180108590A/en
Priority to EP16825728.5A priority patent/EP3389683B8/en
Priority to DK16825727.7T priority patent/DK3389682T3/en
Priority to CA3006859A priority patent/CA3006859A1/en
Priority to EP16825727.7A priority patent/EP3389682B1/en
Priority to BR112018012179A priority patent/BR112018012179A2/en
Priority to EA201891021A priority patent/EA201891021A1/en
Priority to PCT/EP2016/081818 priority patent/WO2017103291A1/en
Priority to MYPI2018702073A priority patent/MY193281A/en
Priority to US16/062,036 priority patent/US11970536B2/en
Priority to CN201680074772.7A priority patent/CN108697745A/en
Priority to KR1020187020442A priority patent/KR20180107105A/en
Priority to BR112018012180A priority patent/BR112018012180A2/en
Priority to AU2016372576A priority patent/AU2016372576A1/en
Priority to US16/062,024 priority patent/US11155622B2/en
Priority to AU2016369485A priority patent/AU2016369485B2/en
Priority to JP2018531336A priority patent/JP7064437B2/en
Priority to EA201891022A priority patent/EA201891022A1/en
Priority to ZA2018/03523A priority patent/ZA201803523B/en
Priority to CONC2018/0005945A priority patent/CO2018005945A2/en
Priority to CL2018001611A priority patent/CL2018001611A1/en
Priority to IL260033A priority patent/IL260033A/en
Priority to PH12018501291A priority patent/PH12018501291A1/en
Ceased legal-status Critical Current

Links

GBGB1617206.6A 2015-12-17 2016-10-10 Method Ceased GB201617206D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB1617206.6A GB201617206D0 (en) 2016-10-10 2016-10-10 Method
EA201891022A EA201891022A1 (en) 2015-12-17 2016-12-19 VIRUS CODING ANTIBODY TO THE TCR COMPLEX OR THE FRAMED ANTIBODY
EA201891021A EA201891021A1 (en) 2015-12-17 2016-12-19 ADENOVIRUS GROUP B, ENCODING ANTIBODY TO THE TCR COMPLEX OR FRAGMENT OF THE INDICATED ANTIBODY
US16/062,036 US11970536B2 (en) 2015-12-17 2016-12-19 Group B adenovirus encoding an anti-TCR-complex antibody or fragment
PCT/EP2016/081818 WO2017103291A1 (en) 2015-12-17 2016-12-19 Virus encoding an anti-tcr-complex antibody or fragment
SG11201805137XA SG11201805137XA (en) 2015-12-17 2016-12-19 Virus encoding an anti-tcr-complex antibody or fragment
SG11201805136TA SG11201805136TA (en) 2015-12-17 2016-12-19 Group b adenovirus encoding an anti-tcr-complex antibody or fragment
CN201680076032.7A CN108697746A (en) 2015-12-17 2016-12-19 Encode the virus of anti-tcr recombinant antibody or segment
MX2018007249A MX2018007249A (en) 2015-12-17 2016-12-19 Group b adenovirus encoding an anti-tcr-complex antibody or fragment.
KR1020187020443A KR20180108590A (en) 2015-12-17 2016-12-19 Anti-TCR-complex viruses that encode complex antibodies or fragments
EP16825728.5A EP3389683B8 (en) 2015-12-17 2016-12-19 Virus encoding an anti-tcr-complex antibody or fragment
DK16825727.7T DK3389682T3 (en) 2015-12-17 2016-12-19 GROUP B ADENOVIRUS CODING AN ANTI-TCR COMPLEX ANTIBODY OR FRAGMENT
CA3006859A CA3006859A1 (en) 2015-12-17 2016-12-19 Group b adenovirus encoding an anti-tcr-complex antibody or fragment
EP16825727.7A EP3389682B1 (en) 2015-12-17 2016-12-19 Group b adenovirus encoding an anti-tcr-complex antibody or fragment
BR112018012179A BR112018012179A2 (en) 2015-12-17 2016-12-19 group b adenovirus encoding an anti-tcr antibody or fragment complex
JP2018531337A JP2019508017A (en) 2015-12-17 2016-12-19 Virus encoding anti-TCR complex antibody or fragment
PCT/EP2016/081817 WO2017103290A1 (en) 2015-12-17 2016-12-19 Group b adenovirus encoding an anti-tcr-complex antibody or fragment
MYPI2018702073A MY193281A (en) 2015-12-17 2016-12-19 Group b adenovirus encoding an anti-tcr-complex antibody or fragment
AU2016369485A AU2016369485B2 (en) 2015-12-17 2016-12-19 Group B adenovirus encoding an anti-TCR-complex antibody or fragment
CN201680074772.7A CN108697745A (en) 2015-12-17 2016-12-19 Encode the B group adenovirus of anti-tcr recombinant antibody or segment
KR1020187020442A KR20180107105A (en) 2015-12-17 2016-12-19 A group B adenovirus encoding an anti-TCR-complex antibody or fragment
BR112018012180A BR112018012180A2 (en) 2015-12-17 2016-12-19 virus encoding an anti-tcr antibody or fragment
AU2016372576A AU2016372576A1 (en) 2015-12-17 2016-12-19 Virus encoding an anti-TCR-complex antibody or fragment
US16/062,024 US11155622B2 (en) 2015-12-17 2016-12-19 Virus encoding an anti-TCR-complex antibody or fragment
IL260027A IL260027B (en) 2015-12-17 2016-12-19 Group b adenovirus encoding an anti-tcr-complex antibody or fragment
JP2018531336A JP7064437B2 (en) 2015-12-17 2016-12-19 Group B adenovirus encoding an anti-TCR complex antibody or fragment
ZA2018/03523A ZA201803523B (en) 2015-12-17 2018-05-28 Group b adenovirus encoding an anti-tcr-complex antibody or fragment
CONC2018/0005945A CO2018005945A2 (en) 2015-12-17 2018-06-12 Group B adenovirus encoding an antibody against the tcr complex or fragment of this
CL2018001611A CL2018001611A1 (en) 2015-12-17 2018-06-14 Group B adenovirus encoding an anti-tcr-complex antibody or fragment
IL260033A IL260033A (en) 2015-12-17 2018-06-14 Virus encoding an anti-tcr-complex antibody or fragment
PH12018501291A PH12018501291A1 (en) 2015-12-17 2018-06-18 Group b adenovirus encoding an anti-tcr-complex antibody or fragment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1617206.6A GB201617206D0 (en) 2016-10-10 2016-10-10 Method

Publications (1)

Publication Number Publication Date
GB201617206D0 true GB201617206D0 (en) 2016-11-23

Family

ID=57610736

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1617206.6A Ceased GB201617206D0 (en) 2015-12-17 2016-10-10 Method

Country Status (1)

Country Link
GB (1) GB201617206D0 (en)

Similar Documents

Publication Publication Date Title
GB201607521D0 (en) Method
GB201609220D0 (en) Method
GB201602394D0 (en) Method
GB201601773D0 (en) Method
GB201608918D0 (en) Method
GB201603367D0 (en) Method
GB201608403D0 (en) Method
GB201607572D0 (en) Alyklation method
GB201602927D0 (en) Method
GB201601120D0 (en) Eye-testing method
GB201617206D0 (en) Method
GB201609241D0 (en) Method
GB201608969D0 (en) Method
GB201608806D0 (en) Method
GB201608848D0 (en) Method
GB201608658D0 (en) Method
GB201608660D0 (en) Method
GB201608469D0 (en) Method
GB201607828D0 (en) Method
GB201607463D0 (en) Method
GB201604898D0 (en) Method
GB201604620D0 (en) Method
GB201604572D0 (en) Method
GB201604291D0 (en) Method
GB201604204D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)